RAC 1.11% $1.83 race oncology ltd

Race Oncology fields promising early results from Zantrene...

  1. 161 Posts.
    lightbulb Created with Sketch. 574
    Race Oncology fields promising early results from Zantrene kidney cancer program
    Circa: 11 March 2022
    Description: Daniel is interviewed on Proactive Investors giving a rundown of the recent ccRCC preclinical resuslts. He explains the commercial relevance of the strong synergy between Zantrene and several other SOC ccRCC drugs; more synergies = more partnering opportunities.


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.